Rise Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Rise Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-253	Closed	-$123K	–	1305
2025 Q3	$123K	Buy	253 +11	+5%	+$5.12K	0.04%	140
2025 Q2	$98K	Sell	242 -13	-5%	-$5.43K	0.04%	153
2025 Q1	$127K	Buy	255 +4	+2%	+$2.17K	0.06%	123
2024 Q4	$130K	Sell	251 -5	-2%	-$2.75K	0.06%	121
2024 Q3	$159K	Buy	256 +2	+0.8%	+$1.18K	0.08%	111
2024 Q2	$141K	Sell	254 -102	-29%	-$58.4K	0.07%	116
2024 Q1	$207K	Buy	356 +206	+137%	+$116K	0.11%	89
2023 Q4	$79.8K	Hold	150	–	–	0.06%	119
2023 Q3	$76.1K	Buy	150 +43	+40%	+$22.9K	0.06%	106
2023 Q2	$55.9K	Sell	107 -3	-3%	-$1.62K	0.04%	136
2023 Q1	$63.5K	Buy	110 +1	+0.9%	+$564	0.05%	139
2022 Q4	$60.1K	Hold	109	–	–	0.05%	139
2022 Q3	$55K	Buy	109 +100	+1,111%	+$56K	0.05%	141
2022 Q2	$5K	Sell	9 -6	-40%	-$3.3K	0.01%	451
2022 Q1	$9K	Hold	15	–	–	0.01%	352
2021 Q4	$10K	Buy	+15	New	+$9.37K	0.01%	326

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Rise Advisors's TMO Position: Q4 2025 in Review

Rise Advisors sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 253 shares — an estimated $123K sold.

Rise Advisors first reported a position in TMO in Q4 2021 and held it in 16 quarters. The position peaked at $207K in Q1 2024. 2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

Rise Advisors reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 253 Thermo Fisher Scientific shares in Q4 2025, an estimated $123K.
Rise Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 16 quarters.
Rise Advisors's Thermo Fisher Scientific position peaked at $207K in Q1 2024.
2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.